Recent Stories
- According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).
- Kevin Tabb, MD (CEO, BILH) joined leadership from local hospitals on the ‘Future of Health Care’ panel and noted health care is moving beyond the four walls of a hospital to any place it’s needed including physician’s offices, community health centers, or a patient’s home.
- According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).
- A research team at BIDMC led by James E. Kirby, MD (Clinical Microbiology, BIDMC) and Ramy Arnaout, MD (Clinical Microbiology, BIDMC) has developed a mathematical model to estimate the false negative rate for COVID-19 tests.
- BIDMC researchers build tool to estimate false negative COVID-19 test rates